On September 3, 2024, Better Choice Company Inc. (NYSE American: BTTR), a pet health and wellness company, signed a definitive agreement to acquire SRx Health Solutions Inc. in an all-stock transaction valued at approximately US$125 million (around C$168 million). SRx Health, a leading Canadian provider of healthcare solutions, operated 35 specialty pharmacy locations, 40 health/infusion clinics, four clinical trial sites, and two distribution facilities across Canada. The acquisition was expected to create operational synergies and new growth opportunities for Better Choice, estimated to generate over US$1.7 million (C$2.3 million) in savings.

Under the terms of the agreement, SRx Health shareholders would own approximately 85% of the combined entity, while Better Choice shareholders would retain 15%. The deal was expected to close in Q4 2024, pending stockholder approvals.

The combined company was set to be led by Adesh A. Vora, SRx Health's current CEO, as Chief Executive Officer of Better Choice. Michael Young was to serve as Chairman.

Wildeboer Dellelce LLP and Meister Seelig & Fein PLLC acted as legal counsel to Better Choice, while Borden Ladner Gervais LLP and Dorsey & Whitney LLP advised SRx Health. ThinkEquity served as an advisor to SRx.